Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2024.1401515
Abstract: Immunotherapy targeted to immune checkpoint inhibitors, such as the program cell death receptor (PD-1) and its ligand (PD-L1), has revolutionized cancer treatment. However, it is now well-known that PD-1/PD-L1 immunotherapy response is inconsistent among patients.… read more here.
Keywords: tracers challenges; imaging tracers; navigating landscape; landscape imaging ... See more keywords